News
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced topline results from its recently completed Phase 2, ...
Zacks.com on MSN1d
Vertex (VERX) Q2 Earnings and Revenues Surpass Estimates
Vertex (VERX) delivered earnings and revenue surprises of +7.14% and +0.17%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback